English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
9 天
Acura制药公司与AD Pharma修订协议,面临财务挑战
伊利诺伊州PALATINE讯 — Acura制药公司(OTC Market: ACUR)是一家专注于开发防滥用药物的微型制药公司,市值仅为USD 0.05百万。根据最新的SEC文件显示,该公司已与Abuse Deterrent Pharma, LLC(AD Pharma)达成修订协议。尽管该公司股票在过去六个月下跌近79%,但年初至今仍上涨300%。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Hits correction territory
Ordered to reinstate workers
CDC nomination withdrawn
Weekly jobless claims fall
200% tariff on EU alcohol?
UN report accuses Israel
Ditch new stadium deal
Democratic Rep. Grijalva dies
Texas Tech closes campus
Asks SCOTUS to intervene
US influencer sparks outrage
Won't block GOP bill
Top FDA lawyer resigns
IRS demotes chief counsel
Exits bankruptcy protection
To host Golden Globes
Police charge stepmother
$3B deal to extend rights
Sister receives bomb threat
Says he supports ceasefire
Indonesian fishermen sue
NY migrant hotels probe
Won't run for Senate in MI
Former NBA center dies
States sue to block layoffs
To test Community Notes
Protective order for accuser
Ex-TX church pastor indicted
Out as creative director
Idaho adopts firing squad
Marks 12th anniversary
New moons orbiting Saturn
反馈